Southern Asia - Press Releases

NEW YORK, April 14, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-02563, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquiredGeron securities between February 28, 2024 and February 25, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

STUART, Fla., April 14, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced its financial results for the first quarter ended March 31, 2025.

SAN DIEGO, April 14, 2025 /PRNewswire/ -- Robbins LLPreminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Actinium Pharmaceuticals, Inc. (NYSE: ATNM) securities between October 31, 2022 and August 2, 2024. Actinium is a late-stage biopharmaceutical company that develops targeted radiotherapies, such as Iomab-B, to treat people who have failed existing oncology therapies.

With UPLIZNA receiving a label expansion that opens the door to a previously untapped rare disease market, Amgen is seeing strong returns on its USD 27.8 billion acquisition of Horizon Therapeutics. The drug has become the first to receive FDA approval specifically for treating immunoglobulin G4-related disease (IgG4-RD).

SHANGHAI, 14 avril 2025 /PRNewswire/ -- La 91e dition du salon China International Medical Equipment Fair (CMEF) s'est acheve le 11 avril 2025 Shanghai, et a permis de prsenter les technologies mdicales rvolutionnaires de prs de 5000exposants et d'attirer des centaines de milliers de participants venus de plus de 150pays.

REAL ID Not Required for Air Travel from May 7th

TORRANCE, Calif., April 14, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA),a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2024.

FRANKILN, Mass., April 14, 2025 /PRNewswire/ -- Amsino has taken a significant step forward in our mission to advance healthcare worldwide. We are proud to announce the establishment of Amsino Scientific Inc., a new medical device manufacturing, research, and development facility based in Franklin, Massachusetts.

INCHEON, South Korea, April 14, 2025 /PRNewswire/ -- Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated YUFLYMA (adalimumab-aaty), as an interchangeable biosimilar to Humira (adalimumab). YUFLYMAis an FDA-approved, high-concentration (100mg/mL) and citrate-free formulation of Humira biosimilar, approved for multiple inflammatory indications.[1]

To further advance oncology with technology, the biotech startup is setting up a 3D cancer pathology lab in the Phoenix-based Discovery Oasis biotech space.

HONG KONG and SHANGHAI, April 14, 2025 /PRNewswire/ -- On April 14, the 2025 Hainan Free Trade Port Global Investment Promotion Conference was held in Haikou. Jointly hosted by the People's Government of Hainan Province and the Ministry of Commerce, the conference is one of the key events in the 2025 "Invest in China" series. With the theme "Invest in Hainan, Connect with the World," the event showcased the achievements, business environment, and investment opportunities of the Hainan Free Trade Port (FTP) to global investors. Wang Qunbin, Co-Chairman of Fosun International, delivered a speech as a representative of key enterprises.

KYOTO, Japan, April 15, 2025 /PRNewswire/ -- Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tamibarotene-related clinical and non-clinical assets from Syros Pharmaceuticals, Inc. (Headquarters: Boston, MA;NASDAQ:SYRS), through a mutual agreement. The acquisition was completed on February 26, 2025.

LONDON, April 15, 2025 /PRNewswire/ -- Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols SA to shareholders of Biotest.

LONDON, April 15, 2025 /PRNewswire/ -- Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols S.A. to shareholders of Biotest:

Acquisition ofTheravia from Mrieux Equity Partners represents meaningful step forward in Norgine's strategy for sustainable growth, adding a complementary portfolio of rare disease medicines

VADUZ, Liechtenstein, April 15, 2025 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2024. The annual report is now available on the company's website.

WASHINGTON, April 14, 2025 /PRNewswire/ -- NASA andSpaceX are targeting 4:15 a.m. EDT, Monday, April 21, for the next launch to deliver science investigations, supplies, and equipment to the International Space Station. This is the 32nd SpaceX commercial resupply services mission to the orbiting laboratory for the agency.

Culmination of Six Year Period of Growth and Strategic Expansion in Partnership with Sterling

MOORESVILLE, N.C. and DALLAS, TEXAS, April 14, 2025 /PRNewswire/ -- Lowe's Companies, Inc. (NYSE: LOW) today announced it has entered into a definitive agreement to acquire Artisan Design Group ("ADG") for $1.325 billion.

ONTARIO, Calif., April 14, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology, today announced that on April 11, 2025, that it has successfully arranged financing with Big Lake Capital, LLC (the "Investor") in the amount of up to $2,000,000 with initial funding of $600,000. Big Lake Capital, LLC is controlled by Tie "James" Li who is our Chairman and CEO.

EDMONTON, AB, April 14, 2025 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) (CSE: SNDL) ("SNDL") announced today that it will release its first quarter 2025 financial results for the period ended March 31, 2025, before market opens on Thursday, May 1, 2025.

ATLANTA, April 14, 2025 /PRNewswire/ -- Georgia-Pacific today announced Keith Hamilton, formerly vice president of operations, Corrugated, has been named president of Georgia-Pacific's Corrugated business. In this role, he will oversee operations and commercial teams across 35 sites including box plants, sheet feeders, Hummingbird digital print, and EarthKraft mailers.

SACRAMENTO, Calif., April 14, 2025 /PRNewswire/ -- Blue Diamond Growers, the largest almond processor and marketer, put out a statement of support following the announcement from USDA Secretary Rollins on release of new Advancing Markets for Producers (AMP) initiative. The Company issued the following statement:

FIRST ALL-FEMALE CREW GOES TO SPACE. AMANDA NGUYEN BECOMES FIRST VIETNAMESE AND SOUTHEAST ASIAN WOMAN TO GO TO SPACE.

Major capital improvement projects showcase Aspen One's ongoing commitment and long-term investment in the world-class Aspen Snowmass experience